TipRanks
Go Ultimate55% OFF

Beijing Tong Ren Tang Chinese Medicine Co (3613) Stock Price & Analysis

3613 Stock Chart & Stats

HK$5.65HK$0.12(2.08%)
At close: 4:00 PM GMT+8
HKD 5.5HKD 6HKD 6.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
HKD 5.55 - HKD 5.68
52-Week Range
HKD 5.40 - HKD 9.50
Previous Close
HKD 5.54
Volume
566.00K
Average Volume (3M)
1.05M
Market Cap
HKD 4.73B
Enterprise Value
HKD 3.52B
Total Cash (Recent Filing)
HKD 2.21B
Total Debt (Recent Filing)
HKD 125.80M
Price to Earnings (P/E)
10.2
Beta
0.45
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
6.55%

Bulls Say, Bears Say

Bulls Say

High Profitability

The company’s high gross and net margins indicate substantial earnings capacity from its TCM portfolio and brand-led sales model. Strong profitability can support product investment, distribution development, and resilience over the next several quarters, provided margins remain defensible.

Conservative Balance Sheet

Minimal leverage gives the company considerable financial flexibility and reduces exposure to interest costs or refinancing pressure. A conservatively financed balance sheet can help preserve investment capacity, support dividends, and absorb operating volatility without relying heavily on new borrowing.

Strong TTM Cash Generation

Recent cash generation closely tracks reported earnings, indicating that TTM profitability is converting into substantial operating and free cash flow. This supports internally funded growth, shareholder distributions, and ongoing business needs without requiring significant external financing.

Bears Say

Uneven Revenue Growth

The recent rebound is encouraging, but declines in multiple annual periods show that top-line expansion has not been consistently steady. Uneven revenue performance can make channel planning and operating leverage less predictable, increasing reliance on continued recovery in demand.

Margin Normalization

Although current profitability remains strong, the lower net margin versus 2021–2022 indicates that earlier earnings economics have not been fully maintained. Continued normalization would reduce the amount of revenue converted into profit and could constrain future returns on growth investment.

Volatile Cash Conversion

The sharp cash-flow reversal followed by recovery suggests that cash conversion can vary materially between reporting periods, potentially because of working-capital timing or other operating movements. Such volatility makes liquidity planning and dependable funding of distributions or expansion more difficult.

Beijing Tong Ren Tang Chinese Medicine Co News

3613 FAQ

What was Beijing Tong Ren Tang Chinese Medicine Co’s price range in the past 12 months?
Beijing Tong Ren Tang Chinese Medicine Co lowest stock price was HK$5.40 and its highest was HK$9.50 in the past 12 months.
What is Beijing Tong Ren Tang Chinese Medicine Co’s market cap?
Beijing Tong Ren Tang Chinese Medicine Co’s market cap is HK$4.73B.
When is Beijing Tong Ren Tang Chinese Medicine Co’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Beijing Tong Ren Tang Chinese Medicine Co’s earnings last quarter?
Beijing Tong Ren Tang Chinese Medicine Co released its earnings results on Aug 28, 2026. The company reported HK$0.24 earnings per share for the quarter.
Is Beijing Tong Ren Tang Chinese Medicine Co overvalued?
According to Wall Street analysts Beijing Tong Ren Tang Chinese Medicine Co’s price is currently Undervalued.
Does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?
Beijing Tong Ren Tang Chinese Medicine Co pays a Notavailable dividend of HK$0.4 which represents an annual dividend yield of 6.55%. See more information on Beijing Tong Ren Tang Chinese Medicine Co dividends here
What is Beijing Tong Ren Tang Chinese Medicine Co’s EPS estimate?
Beijing Tong Ren Tang Chinese Medicine Co’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Tong Ren Tang Chinese Medicine Co have?
Beijing Tong Ren Tang Chinese Medicine Co has 837,100,000 shares outstanding.
What happened to Beijing Tong Ren Tang Chinese Medicine Co’s price movement after its last earnings report?
Beijing Tong Ren Tang Chinese Medicine Co reported an EPS of HK$0.24 in its last earnings report. Following the earnings report the stock price went down -0.307%.
Which hedge fund is a major shareholder of Beijing Tong Ren Tang Chinese Medicine Co?
Currently, no hedge funds are holding shares in HK:3613
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology